We scan new podcasts and send you the top 5 insights daily.
When reviewers are conditioned to expect AI flaws, tests show that many invent non-existent errors in perfectly clean text. Over-scrutinizing creates massive business friction, slowing output without increasing safety. Rather than tripling the verification load across every draft, review rigor must be systematically calibrated according to the regulatory and clinical consequences of the document rather than a reviewer's subjective feelings of uncertainty.
While 'human in the loop' is a standard AI safety practice, it becomes an operational bottleneck at enterprise scale. When hundreds of AI agents generate thousands of actions requiring review, the human capacity to oversee them is the limiting factor, rendering the system impractical for high-volume, real-time operations.
Beyond model capabilities and process integration, a key challenge in deploying AI is the "verification bottleneck." This new layer of work requires humans to review edge cases and ensure final accuracy, creating a need for entirely new quality assurance processes that didn't exist before.
A teammate of Charlie Marsh admitted they now review his pull requests more carefully, saying, 'you're not writing it anymore, it's the agent.' This highlights a hidden cost of AI adoption: it can break down the earned trust and review shortcuts that senior engineers typically benefit from.
As AI models advance and establish cleaner track records, human verification drops due to automation bias. A system that fails half as often, reviewed half as carefully, leaves biopharma companies in a worse position because remaining failures are subtler and masked by fluent prose. The apparent success of an AI pilot naturally lowers reviewer vigilance, allowing high-risk errors to circulate undetected.
Traditional pharma review processes implicitly depend on knowing a human author's personal habits, such as overclaiming when excited or becoming vague in regulatory sections. Generated AI text erases these fingerprints. It delivers genuine citations and fabricated claims with identical tone, fluency, and authority. Reviewers lose the intuitive mental map of where weak evidence lies, forcing an unnatural shift from noticing obvious tells to actively hunting invisible omissions.
Effective "human-in-the-loop" systems don't require people to re-read every AI-processed document. Instead, the system flags low-confidence or ambiguous results for human review. This shifts the human role from transcriber to verifier, focusing expertise on exceptions and creating a valuable feedback loop.
Human verification catches AI output errors, but a deeper trust crisis is emerging. Executives, regulators, and partners are losing confidence in the underlying AI systems, their governance, and strategic recommendations, even when individual outputs are correct.
Research shows cognitive, accuracy-based skills (like judging if an AI-generated draft is defensible) erode far more quickly than procedural skills (like running a workflow). This means teams lose their most critical risk-management capability—the ability to spot a plausible but incorrect AI output—first.
AI assurance collapses when human verification is treated purely as a signature collection process. If challenging or rejecting an AI draft is awkward, slow, or organizationally discouraged, genuine oversight does not exist. Effective control is an organizational design challenge requiring teams to explicitly designate individuals who hold the dedicated time, professional standing, and clear mandate to reject and return AI-generated text.
Distortion errors frequently disguise themselves as crisp, competent editing. When summarizing clinical documentation, an AI may compress a narrow demographic into a broad indication, expanding the patient population without explicitly stating a falsehood. Similarly, hedged statements like 'suggested' silently become 'evidence shows'. Because the resulting text is punchier and reads better, human reviewers routinely mistake substantive clinical overstatements for standard summarization.